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Photodissociation of TEMPO-modified peptides: new approaches to radical-
directed dissociation of biomolecules 
Abstract 
Radical-directed dissociation of gas phase ions is emerging as a powerful and complementary alternative 
to traditional tandem mass spectrometric techniques for biomolecular structural analysis. Previous 
studies have identified that coupling of 2-[(2,2,6,6-tetramethylpiperidin-1-oxyl)methyl]benzoic acid 
(TEMPO-Bz) to the N-terminus of a peptide introduces a labile oxygen–carbon bond that can be 
selectively activated upon collisional activation to produce a radical ion. Here we demonstrate that 
structurally-defined peptide radical ions can also be generated upon UV laser photodissociation of the 
same TEMPO-Bz derivatives in a linear ion-trap mass spectrometer. When subjected to further mass 
spectrometric analyses, the radical ions formed by a single laser pulse undergo identical dissociations as 
those formed by collisional activation of the same precursor ion, and can thus be used to derive 
molecular structure. Mapping the initial radical formation process as a function of photon energy by 
photodissociation action spectroscopy reveals that photoproduct formation is selective but occurs only in 
modest yield across the wavelength range (300–220 nm), with the photoproduct yield maximised 
between 235 and 225 nm. Based on the analysis of a set of model compounds, structural modifications 
to the TEMPO-Bz derivative are suggested to optimise radical photoproduct yield. Future development of 
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Radical-directed dissociation of gas phase ions is emerging as a powerful and 
complementary alternative to traditional tandem mass spectrometric techniques for 
biomolecular structural analysis. Previous studies have identified that coupling of 2-[(2,2,6,6-
tetramethylpiperidin-1-oxyl)methyl]benzoic acid (TEMPO-Bz) to the N-terminus of a peptide 
introduces a labile oxygen-carbon bond that can be selectively activated upon collisional 
activation to produce a radical ion. Here we demonstrate that structurally-defined peptide 
radical ions can also be generated upon UV laser photodissociation of the same TEMPO-Bz 
derivatives in a linear ion-trap mass spectrometer. When subjected to further mass 
spectrometric analyses, the radical ions formed by a single laser pulse undergo identical 
dissociations as those formed by collisional activation of the same precursor ion, and can thus 
be used to derive molecular structure. Mapping the initial radical formation process as a 
function of photon energy by photodissociation action spectroscopy reveals that photoproduct 
formation is selective but occurs only in modest yield across the wavelength range (300 – 220 
nm), with the photoproduct yield maximised between 235 and 225 nm. Based on the analysis 
of a set of model compounds, structural modifications to the TEMPO-Bz derivative are 
suggested to optimise radical photoproduct yield. Future development of such probes offers 




In the field of proteomics, radical-based tandem mass spectrometry of peptides and 
proteins is a powerful alternative tool to collision-induced dissociation (CID). Whilst their 
speed and simplicity cannot be disputed, “slow-heating” methods
1
 such as CID or infrared 
multi-photon dissociation (IRMPD) generally promote even-electron fragmentation of the 
peptide or protein ion, and used in isolation may not provide full sequence coverage or 
complete characterisation of labile post-translational modifications (PTMs).
2, 3
 Compared to 
CID or IRMPD, electron capture dissociation (ECD)
4-7
 and electron transfer dissociation 
(ETD)
8, 9
 of multiply-charged peptide/protein cations typically produce spectra with greater 
sequence coverage and PTM localisation, due to extensive, non-selective fragmentation.
9, 10
 





charged peptide ions also elicits additional radical driven sequence coverage information 
complementary to that derived from collisional activation, without modifying the initial 
charge state. 
The increasing importance of radical ions in biomolecular mass spectrometry has 
motivated development of chemical methods for introducing radical sites into peptide/protein 
ions that are applicable to a wider range of mass spectrometer configurations. For example, 
CID of ternary metal/peptide complexes generate peptide radical cations,
14
 which produce 
a/x- or c/z-type peptide backbone fragments and notable side chain losses upon subsequent 
activation.
15-19
 Covalent attachment of a free radical precursor to peptides is another pathway 
to produce peptide radical ions, by introducing a labile bond that is susceptible to homolysis. 
Free-radical initiated peptide sequencing (FRIPS) methods offer the particular advantage of a 
well-defined initial radical site, thus fragmentation can be induced at specific amino acid 
 4 
residues. For example, collisional activation of N-nitroso- and S-nitroso-derivatives of 
tryptophan and cysteine-containing peptides produce aminyl and sulfenyl radicals through 
bond homolysis with loss of nitric oxide. Subsequent activation of these radical ions initiates 




Chemical modification of the N-terminus of the peptide or protein is another example 
of derivitisation for FRIPS. For instance, upon CID, peroxycarbamates
25
 and azo moieties
26
 
are susceptible to homolytic dissociation forming nitrogen- and carbon-centred radicals, 
respectively. Collisional activation of such radical ions results in side-chain and backbone 
cleavage with extensive sequence coverage. Lee et al. introduced 2-[(2,2,6,6-
tetramethylpiperidin-1-oxyl)methyl]benzoic acid (TEMPO-Bz, Scheme 1) as a free radical 
precursor bound to peptides through the N-terminus or at the ε-amine of lysine residues,
27-29
 
and is the tagging group employed in the present study. Collisional activation of the precursor 
peptide ions initiates homolytic cleavage of the labile NO-C bond, promoted by the 
remarkable stability of the released nitroxyl radical. Subsequent collisional activation of the 
peptide radical ions yields peptide backbone fragments and side-chain losses with extensive 
sequence coverage. Abundant formation of a/x-and c/z-type ions suggests that radical-driven 




Scheme 1: Peptide-TEMPO-Bz structure used in this study. Activation of the derivatised 
peptide by either (a) collision-induced dissociation (CID, shown previously) or (b) 
photodissociation (PD, shown here) results in homolytic cleavage of the carbon-oxygen bond, 
and neutral loss of the TEMPO moiety (-156 Da) to yield a peptide radical ion. 
 
Ultraviolet photodissociation (UVPD) has also been used extensively for peptide 
characterisation and sequencing.
30
 The identity and yield of photoproduct ions depends on 
many aspects, including the incident photon energy, chemical modifications to the peptide,
31
 
ion charge-state, laser fluence, overlap between the incident light and the ion ensemble, 
absorption cross-section, and the number of pulses with which the ion ensemble is 
irradiated.
32
 The complexity of laser-based structural characterisation is increased for large 
molecules as bond dissociation can be mediated by the redistribution of excess energy among 
many vibrational degrees of freedom.
33
 The energy required for radical formation through 
bond homolysis can thus exceed the intrinsic bond dissociation energy. In order to form 
protein radical ions in the gas phase by UV irradiation, it is therefore necessary to induce 
dissociation on a time scale faster than competing processes, including intramolecular 
vibrational energy redistribution (IVR). IVR extends the lifetime of the activated ion 
population and provides opportunity for non-dissociative removal of excess energy via 
collisional cooling. One such example is electron photodetachment from polyanions.
34
 
Peptide radical anions are formed by efficient UV excitation of bound π*←π electronic 
transitions within aromatic amino acids, followed by crossing to unbound electronic states, 
leading to electron detachment on a timescale that is competitive with IVR. 
Photolysis of suitable photolabile precursors is an alternative way to efficiently 
produce a radical site for peptide sequencing. For example, upon irradiation with 266 nm 
photons, iodine atom loss from aryl iodide-modified peptide ions is observed as the major 
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process in the mass spectrum.
35-37
 Kirk et al. recently demonstrated the wavelength 
dependence of iodine atom loss from iodo-tyrosines by photodissociation (PD) action 
spectroscopy, highlighting the influence of charge state on the efficacy of photoproduct 
formation.
38
 Compared with CID, photodissociation of aryl iodides facilitates the production 
of radical sites without complications due to isomerisation.
39, 40
 Strategies that utilise UV 
radiation and a photolabile radical precursor show promise for peptide characterisation. High 
photoproduct yields,
41
 the availability of tuneable laser sources, and avoiding the low-mass 
cut-off inherent in ion trap-based analysis
42
 offer an opportunity for enhanced peptide 
sequencing coverage over collisional and electron-based tandem mass spectrometric methods. 
Photodissociation can access site-specific radical ion product channels, whereas collisional 
activation of the same precursor ion yields less selective fragmentation, a mixture of isomers, 
or no radical-directed dissociation at all.
43, 44
 
In the present study, we have explored the application of UVPD to TEMPO-Bz 
modified peptides and assessed the suitability of this strategy for FRIPS. Here we show that 
absorbed UV radiation induces homolytic cleavage of the labile carbon-oxygen bond in the 
TEMPO-Bz derivatives. Thus generated, the peptide radical ions can be further activated by 
CID to fragment the peptide backbone, resulting in sequence ions and diagnostic side chain 
losses. In this study, the factors influencing the efficacy of photodissociation are explored and 





Methanol (HPLC grade), acetic acid (99%, AR grade), and ammonium acetate (AR 
grade) were obtained from Ajax Fine Chemicals (now part of Thermo Fisher Scientific, 
Sydney, Australia). All other materials were obtained from Sigma Aldrich (Sydney, 
Australia). The synthesis of TEMPO-Bz conjugated peptides from commercially available 2-
methylbenzoic acid methyl ester has been reported previously.
27
 Peptide solutions of 
kinetensin (IARRHPYFL), bradykinin (RPPGFSPFR), and YGGFMRF were prepared at ca. 
10 – 20 µM, in 1:1 methanol:water solvent mixtures, with the addition of 0.1% acetic acid or 
0.1% ammonium acetate to facilitate the formation of positive and negative ions, 
respectively. Synthesis of model compounds 1-(benzyloxy)-2,2,6,6-tetramethylpiperidine-4-
carboxylic acid (1); 4-(((1-(benzyloxy)-2,2,6,6-tetramethylpiperidin-4-
yl)oxy)carbonyl)cyclohexanecarboxylic acid (2); and 4-(((1-(benzyloxy)-2,2,6,6-
tetramethylpiperidin-4-yl)oxy)carbonyl)benzoic acid (3) was undertaken based on 
appropriate adaptation of literature procedures. Briefly, 1 was prepared by the addition of 
phenylacetaldehyde, hydrogen peroxide and copper (I) to 4-carboxy-TEMPO (1a). 4-
hydroxy-TEMPO-Bz is prepared from 4-hydroxy-TEMPO in the same manner,
45
 and is 
subsequently esterified with the appropriate difunctional acid in the presence of N,N’-
dicyclohexylcarbodiimide (DCC) and 4-(dimethylamino)pyridine (DMAP). Desired [M − 
H]
−
 anions of (1-3) are produced without additional purification by diluting aliquots of the 
reaction mixture to a concentration of approximately 5 µM in methanol, and subjecting these 
solutions to electrospray ionisation (ESI). A summary table listing all peptides investigated in 
 8 
this study and the charge states that were subjected to photodissociation is provided as 
Supporting Information (Table S1). 
 
Mass Spectrometry  
Photodissociation experiments were performed using a Thermo Fisher Scientific  





 laser photodissociation experiments. Briefly, the 
aforementioned peptide solutions are infused into the mass spectrometer through the ESI 
source with instrument parameters similar to those described previously.
27
 The TEMPO-Bz 
modified peptide ions are mass-selected, isolated, and thermalised (ca. 307 K)
48
 in the helium 
buffer gas (2.5 mTorr helium). The ion ensemble is then irradiated with a single pulse from 
either a fixed-frequency (266 nm) or tunable (300 – 220 nm) nanosecond laser system, the 
ion trap is scanned out and a PD mass spectrum is recorded containing signals for both 
photoproduct ions and the intact precursor ion population. In a photodissociation action 
spectroscopy experiment, the photodissociation yield is calculated as a fraction of the total 
ion population from this mass spectrum, the laser is then tuned to the next wavelength and the 
process repeated. For each action spectrum, the photoproduct yields are corrected by a power 
spectrum (acquired offline), and plotted as a function of photon wavelength.
47
 
The fixed-frequency experiments are performed using the 4
th
 harmonic (266 nm) of a 
Nd:YAG laser (Continuum Minilite, Santa Clara, CA, USA), delivering a 5 ns, 4 mJ pulse on 
demand. Tunable photodissociation experiments employ an optical parametric oscillator 
(OPO) fitted with a frequency-doubling unit (versaScan and uvScan, GWU-Lasertechnik, 
Erftstadt, Germany) pumped by the 3
rd
 harmonic (355 nm) of a QuantaRay INDI Nd:YAG 
laser (Spectra-Physics, Santa Clara, CA, USA). This provides a pulsed, nanosecond photon 
source, tunable across the range 2500 – 220 nm, delivering ca. 2 mJ per pulse in the UV. This 
 9 
laser operates at 10 Hz and is carefully shuttered to ensure that only a single pulse enters the 






Photodissociation of derivatised peptides 
Electrospray ionisation of TEMPO-Bz peptide solutions produced singly and multiply 
charged ions, with the relative abundance of charge states dependant on ion source 
parameters, solvent composition, and the number of acidic and basic amino acid residues in 
the peptide. CID spectra resulting from the isolation and activation of [M + nH]
n+
 ions (where 
n = 1, 2) of bradykinin-TEMPO-Bz are displayed in Figure 1. Prior to activation, no product 
ions are observed from either precursor ion. The carbon-oxygen bond energy in the TEMPO-
Bz motif is estimated
49
 to be only 110 kJ mol
–1
 and thus upon CID, the bond between the 
nitroxyl oxygen and the benzyl carbon is preferentially cleaved to form an abundant radical 
ion (m/z 589 and m/z 1177 for doubly and singly charged ions, Figure 1(a) and 1(c), 
respectively). The resulting alkyl radical initially formed at the benzylic position remains 
covalently tethered to the N-terminus of bradykinin (cf. Scheme 1).
27
 Additional product ions 
present in low abundance are attributed to spontaneous, radical-mediated backbone cleavage 
(e.g., c5
+
) or amino acid side chain losses (e.g., -100 Da, from arginine) from the primary 
radical product (vide infra). When the isolated precursor ions are irradiated with a single, λ = 
266 nm laser pulse (henceforth PD266), the doubly and singly protonated ions (Figure 1(b) 
and 1(d), respectively) undergo TEMPO loss through carbon-oxygen bond homolysis. 
Despite the perceived selectivity, the yield of desired radical ions is much lower in the PD266 
spectra (less than 4% of the precursor ion abundance), compared to the almost complete 
conversion achieved by CID. In the PD266 experiment, the relative abundance of the open-
shell product ion is higher from the singly protonated charge state, compared to the doubly 




Figure 1: Mass spectra obtained upon isolation and CID (normalised collision energy of 20) 
or PD266 irradiation of protonated TEMPO-modified bradykinin (RPPGFSPFR) ions, 
exhibiting selective loss of TEMPO; (a) CID of [M + 2H]
2+
 ions; (b) PD266 of [M + 2H]
2+
 
ions; (c) CID of [M + H]
+
 ions; (d) PD266 of [M + H]
+
 ions. Peaks denoted by numbers 
represent the mass difference after TEMPO loss, and the letter in parentheses indicates the 
amino acid involved.  
Except for the y8
+
 ion observed in the CID spectrum of derivatised bradykinin (Figure 
1a), characteristic b-type and y-type product ions from the intact modified peptide, typically 
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observed from collisional activation of protonated peptide ions,
50, 51
 are notably minor in both 
the CID and PD266 spectra. Although an intact b1
+
 ion is not observed in Figure 1(a), a radical 
ion is present corresponding to formation of a b1
+
 ion after TEMPO loss, indicating that loss 
of a TEMPO radical via homolysis is the preferred dissociation process. Additional b-type 
and y-type ions are present following PD266 of the derivatised bradykinin but are of too low 
abundance to be readily identified at the magnifications shown in Figures 1(b) and (d). 
Notably however, when the abundance of b-type and y-type ions are considered relative to 
the abundance of the [M + xH – TEMPO]
x+•
 ion (rather than the precursor ions as displayed 
in Figures 1b and 1d) similar peak ratios are found for PD266 as CID spectra (see Supporting 
Information, Figure S1a). Indeed, some comparable b-type and y-type ions are observed in 
the PD266 spectrum of unmodified bradykinin (i.e., in the absence of the TEMPO-Bz tag, see 
Supporting Information, Figure S1b). 
Activation of [M + 3H]
3+ 
TEMPO-modified bradykinin ions (m/z 445) by CID also 
produces ions attributed to TEMPO loss at m/z 393 (see Supporting Information Figure S2). 
However selectivity is not retained, and the CID spectrum is dominated by ions with higher 
mass-to-charge ratios, indicating charge reduction fragmentation mechanisms prevail over the 
desired radical formation by homolysis of the oxygen-carbon bond. Likewise, irradiation of 
the [M + 3H]
3+
 ions by PD266 does not result in TEMPO loss. This may be rationalised by 
considering that after the basic arginine residues, the final protonation site is likely to be the 
piperidinyl nitrogen of the TEMPO-Bz moiety. Upon protonation of the piperidinyl nitrogen, 
homolysis of the alkoxyamine NO-C bond is suppressed relative to even-electron 
rearrangement processes under CID,
52
 and we infer that analogous processes prevail upon 
photodissociation. Similar observations were made for other peptides when the number of 
charges approached or exceeded the number of basic side chains available, placing an upper 




Advantageously, the TEMPO-based FRIPS methodology is also applicable to the 
study of negative ions.
29
 Negative ion mass spectrometry provides structural information for 
proteomics that is both confirmatory and complementary to that obtained in the study of 
positive ions. Furthermore, for peptides with acidic residues or phosphorylation, negative ion 
mass spectrometry may be preferred for increased sensitivity. By contrast with positive ions, 
only a few studies have considered the formation and fragmentation of site-specific peptide 
radical anions with the aim of peptide sequencing and characterisation.
43, 54
 Singly and 
multiply deprotonated TEMPO-Bz peptide anions [M – H]
–
 and [M – 2H]
2–
 were produced 
by ESI, depending on the number of acidic residues available in the peptide. For example, 
isolation and PD266 of kinetensin dianions produces the spectrum shown in Figure 2(a). It is 
clear from the presence of [M – 2H]●
–
 product ions at m/z 1442 that electron detachment 
competes with TEMPO photodissociation. A putative biradical anion at m/z 1286 arises from 
a combination of both electron detachment and bond homolysis processes. For singly charged 
anions (m/z 1443, Figure 2b), selective loss of TEMPO is observed, producing a radical anion 
at m/z 1287. Electron detachment is also prevalent for the singly charged anions, forming 
unobservable neutral products, and reducing the total ion signal by ca. 10% when compared 
with a spectrum obtained with the laser beam blocked. Like the protonated species, higher 
photoproduct ion abundance is observed for the lower charge state, specifically 1.6% for 
singly charged kinetensin anions, compared to 0.2% for the dianions. Unlike the previously 
published CID spectrum,
29
 diagnostic sequence ions were not found to be abundant following 
UV irradiation of the precursor anions. 
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Figure 2: Mass spectra obtained upon isolation and irradiation of deprotonated TEMPO-Bz 
modified kinetensin (IARRHPYFL) ions, exhibiting ions attributable to bond homolysis and 
electron detachment; (a) PD266 of [M – 2H]
2– 
ions, where the abundance of ions other than 
m/z 721 and 1442 have been magnified by 50 times; (b) PD266 of [M – H]
–
 ions, where the 
abundance of ions other than m/z 1443 have been magnified by 50 times. 
Despite the comparably high selectivity for NO-C bond homolysis observed by both 
activation methods, the production of peptide radical ions through TEMPO loss (cf. Scheme 
1) is less prevalent for PD266 than for CID. The efficacy of the latter can also be easily 
modulated, by adjusting the activation energy applied to the trapped ions. The modest yield 
from PD266 irradiation was found to be consistent for all peptides studied, with a small 
improvement in PD266 photoproduct yields for singly charged ions, compared to doubly 
charged ions. The maximum raw photoproduct ion abundance observed was ca. 10.5% 
relative to the precursor ion, for singly protonated YGGFMRF. By comparison, the radical 
photoproduct yield of the equivalent [M + 2H]
2+
 ion was only 0.2%, and 2.3% for the [M – 
H]
–
 ion (see Supporting Information, Figure S3). 
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Characterisation of radical ions  
Despite overall low PD yields, sufficient radical photoproduct ions were produced to 
enable further interrogation through MS
n
 experiments in the linear ion trap, and allow 
comparison of the radical ions initially formed by CID and PD266. Such ions are matched by 
comparing CID/CID (MS
3




spectra. For example, 
[M + 2H]
2+
 ions of modified YGGFMRF (m/z 576) are subjected to CID and PD266 to form 
radical ions (m/z 498) via loss of TEMPO. Upon subsequent isolation and collisional 
activation, CID/CID and PD266/CID spectra were acquired. These spectra are compared in 
Figure 3(a) and 3(b), respectively, and exhibit the same product ions at similar relative 
abundances. The highest intensity product ion peak is a doubly charged c6 ion, which can 
only feasibly be generated by radical-driven processes. Hydrogen atom transfer is proposed 
to explain the radical mediated backbone cleavage and side chain losses observed in FRIPS, 
and the relationship to peptide structure.
26, 55
 Independent of charge state, hydrogen atom 
transfer from the amino acid side chain to the benzylic radical results in a peptide-based 
radical with a closed-shell o-methylbenzamide modification at the N-terminus.
27
 Subsequent 
β-cleavage of the peptide-based radical yields a/x- and c/z-type ions. Side chain losses are 
also observed, with diagnostic mass losses identifying specific amino acid residues, such as 
the 61 Da loss (CH3SCH2
•
) specific to methionine (Figure 3b). Noticeably, an array of b- and 
y-type ions are also observed in both MS
3
 spectra. As there are more protons than basic 
arginine residues, conventional mobile-proton-assisted (rather than radical-driven) backbone 
dissociation is responsible for the formation of these ions.
56
 Based on the similarities between 
the two MS
3
 spectra, the radical ion species formed by both CID and PD activation methods 
are identical. Therefore, PD266/CID may be used to obtain the same structural information as 
CID/CID, albeit with a lower radical ion abundance. 
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As a further example, the PD266/CID spectrum of doubly charged bradykinin is shown 
in Figure 3(c). Predominantly a-type ions are observed, along with b-, c-, y-, and z-type ions, 
as well as radical-driven side chain losses associated with arginine. This MS
3
 spectrum shares 
several features with a result obtained by Sun et al., whereby doubly protonated bradykinin 
radical ions were generated through PD266 of a non-covalent complex, and subsequently 
subjected to CID.
57
 Fragmentation is preferentially observed at aromatic phenylalanine 
residues, producing a5 and a8 ions. As a consequence of cleavage between phenylalanine and 
serine, c5 and z4 ions are also observed. The proline effect governs the formation of abundant 
y8 ions. However, compared to YGGFMRF, b-type and y-type ions are otherwise suppressed 
in bradykinin, due to the sequestration of charge on multiple arginine residues. Like 
bradykinin, the PD266/CID spectrum of kinetensin (IARRHPYFL, Figure 3d) is dominated by 
a-type ions, and fragmentation of the side chain of the first amino acid from the N-terminus, 
namely a 29 Da loss (CH3CH2
•
) from isoleucine. Other radical-driven side chain losses from 
tyrosine and arginine are also observed. Comparing with the equivalent CID/CID spectra for 
bradykinin and kinetensin (Supporting Information, Figure S4 and Figure S5, respectively) 
confirms that the radical ion species initially produced by CID and PD266 are essentially 
equivalent, and thus provide the same structural information. Importantly, these results 
confirm that the structure of radical ions produced from TEMPO-Bz derivatives of peptides 
are identical regardless of the activation method used to generate them. The sensitivity and 
thus the utility of PD266 irradiation is hampered however by the low photoproduct yields; 





 spectra obtained following CID of [M + 2H – TEMPO]
2+•
 radical ions: (a) 
YGGFMRF, generated by CID; (b) YGGFMRF, generated by PD266; (c) bradykinin, 
generated by PD266; (d) kinetensin, generated by PD266. Major peptide sequence ions and 
radical mediated side chain losses are assigned, with the identified amino acid in parentheses. 





Photodissociation action spectroscopy of derivatised peptides 
To investigate the possibility of improving the radical photoproduct yield by varying 
the incident photon energy, PD action spectra are acquired across a wavelength range of 300 
– 220 nm in one nanometre increments. Photofragmentation is not observed when the 
wavelength is tuned further to the red (λ > 300 nm), consistent with previous observations of 
the photolysis of the TEMPO-Bz moiety.
58
 Plotting the power-corrected photodissociation 
yield of the [M + 2H – TEMPO]
2+•
 product ion from the [M + 2H]
2+
 ions of both bradykinin 
and kinetensin against the photon wavelength results in the PD action spectra shown in 
Figure 4. The maximum photodissociation yield for bradykinin occurs around 227 nm, and 
for kinetensin around 232 nm. Changes in photodissociation action spectrum profile may be 
used as indicators for variations in the primary or secondary structure of small peptides.
38
 
Differences in the PD action spectra between kinetensin and bradykinin are qualitatively 
attributed to the different number and type of aromatic residues (chromophores) in the 
peptide, and their proximity to the N-terminus, where the dissociation occurs. Although it 
must be noted that the absolute photoproduct yields acquired with different lasers may not be 
directly comparable, the low photodissociation yield at longer wavelengths correlates with 
low photoproduct yields observed using the fixed-frequency 266 nm laser (maximum raw 
photoproduct abundance ca. 2% for doubly charged peptide ions). Based on these data, 266 
nm does not correspond to the ideal photon energy to efficiently induce dissociation of the 
NO-C bond in TEMPO-modified peptides with more efficient conversion to the radical ions 
achieved near 230 – 225 nm (representing an increase in yield of ca. 20-50 fold). 
 19 
 
Figure 4: Photodissociation action spectra exhibiting the relative yield of [M + 2H − 
TEMPO]
2+•
 photoproducts from TEMPO-Bz modified bradykinin and kinetensin [M + 2H]
2+
 
ions as a function of wavelength. The PD action spectrum plotting the y8
+
 product ion from 
bradykinin has a similar profile to that of the [M + 2H − TEMPO]
2+•
 photoproduct ion, both 
action spectra are compared in Figure S6 in the Supporting Information. Representative 
photodissociation mass spectra for both TEMPO-Bz modified peptides are also provided as 
Supporting Information, Figure S7 and Figure S8. 
Proteins as large as ubiquitin, modified to contain an iodo-tyrosine residue, produce 
abundant radical ions upon PD266 (at a similar fluence to that employed herein), through 
homolysis of the aryl carbon-iodine bond on an excited state surface,
59, 60
 which is known to 
occur on the sub-picosecond timescale following excitation.
47
 By contrast, although the 
photon energies employed herein (300 nm = 399 kJ mol
-1
) exceed the NO-C bond 
dissociation energy in TEMPO-Bz (ca. 110 kJ mol
-1
), the excess energy does not result in the 
formation of abundant photoproduct ions via homolysis. The modest abundance of peptide 
radical ions by PD may be a result of poor absorption cross-section, or a large population of 
the ions redistributing their excess energy via non-dissociative relaxation pathways (e.g., 
collisional cooling). Photodissociation of the NO-C bond in the TEMPO-Bz moiety therefore 
warranted further investigation. 
 20 
The formation of y8
+
 ions (m/z 904), observed in the CID spectra of both unmodified
61
 
and TEMPO-Bz modified bradykinin (Figure 1a), also proceeds upon ultraviolet excitation of 
the latter. Formation of y8
+
 ions as a function of wavelength exhibits a similar profile to that 
of the TEMPO loss product (see Supporting Information, Figure S6), which suggests that 
both products are formed by similar processes following photo-excitation. The dissociation to 
yn
+
 ions is known to be facilitated by vibrational excitation on the electronic ground state 
surface.
62
 Therefore, TEMPO loss through oxygen-carbon bond dissociation also likely 
occurs following excitation and internal conversion to a vibrationally-excited electronic 
ground-state. Previous work has suggested, that the branching ratio between excited state 
fragmentation and ground state fragmentation is variable, depending on the peptide sequence 
and conformation, charge state, and charge site.
63, 64
 In some cases, internal conversion is so 
dominant that excited state-specific fragmentation is completely quenched;
62
 this appears to 
be the case here. We surmise therefore, that UV photodissociation of the derivatised peptides 
kinetensin and bradykinin is occurring on their respective ground electronic states. 
Differences in their photoaction spectra (Figure 4) thus reflect variation in absorption profile, 
resulting from differences in primary and secondary structure, rather than participation of any 
particular excited-state dissociation mechanisms. 
 
Photodissociation of model compounds 
In order to better understand – and potentially improve – the apparently poor 
efficiency of NO-C photodissociation in the TEMPO-Bz system, model compounds (1-3) 
were synthesised and subjected to PD266 irradiation (Figure 5). Isolation and 
photodissociation of the [M – H]
–
 anions formed from 4-carboxy-TEMPO-Bz (1) selectively 
produce radical anions at m/z 199 in modest yield, through cleavage of the NO-C bond and 
neutral loss of the benzyl radical moiety (Figure 5a). Further interrogation of the m/z 199 ions 
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by CID resulted in an MS
3 
(PD266/CID) spectrum identical to: (i) the MS
3
 (CID/CID) 
spectrum produced by successive CID steps from the same precursor ion (1); and (ii) the CID 
spectrum obtained from the [M – H]
–
 anion formed by ESI of an authentic sample of 4-
carboxy-TEMPO (1a) (see Supporting Information, Figure S9). Although much smaller in 
size than the studied peptides, photodissociation of the NO-C bond in this system indicates 
that the chromophore present on the TEMPO-Bz linker is also able to initiate homolysis. 
Therefore, peptides without aromatic residues may also be amenable to photodissociation 
using this tagging group. With this prototype system, the photoproduct yield is ca. 3% 
relative to the precursor ion and is similar in magnitude to the maximum PD266 efficiency 
observed for the TEMPO-modified peptides. A similarly modest photoproduct yield (ca. 4%) 
is also observed when, for compound (2), a cyclohexyl linker is added between TEMPO-Bz 
and the carboxylate charge carrier (Figure 5b). The TEMPO-Bz moiety does not undergo 
efficient bond homolysis at 266 nm, despite the stability of the putative distonic nitroxyl 
radical anion products (1a) and (2a).
65
 In the third model compound (3) an additional 
aromatic chromophore was installed at the 4-position of the piperidine ring. Compared with 
(1) and (2), the benzyl loss photoproduct yield from [M – H]
–
 anions formed from (3) is 
greatly enhanced, contributing over 50% of the total ion population. In addition to the major 
photoproduct arising from loss of the benzyl moiety (3a), a secondary product ion is also 
observed at m/z 304, corresponding to subsequent loss of a methyl radical. Covalent 
attachment of an additional aromatic chromophore to the 4-position of the piperidine ring 
improves the photodissociation yield in the TEMPO-Bz motif more drastically than variation 
of chromophores on the peptide backbone, potentially through increased absorption cross-







Figure 5: PD266 of the [M − H]
−
 anions formed from model TEMPO-Bz compounds 1-3 
produce the respective nitroxyl radicals (1a-3a): (a) 1-(benzyloxy)-2,2,6,6-
tetramethylpiperidine-4-carboxylic acid (1); (b) 4-(((1-(benzyloxy)-2,2,6,6-





Photodissociation of TEMPO-Bz conjugated peptide ions were carried out in a 
modified linear ion trap mass spectrometer coupled to two laser systems. Despite modest 
yields of radical photoproducts, further MS
n
 interrogation confirms the structural identity of 
the formed radical to be the same as that afforded by CID of the same precursor ion, yielding 
a similarly informative mass spectrum. Wavelength dependence of the photodissociative 
radical formation step by action spectroscopy reveals a maximum photoproduct yield around 
230 nm, contingent on the charge state and peptide sequence.  
The results from photodissociation of model systems suggests that the proximity of 
additional chromophores improves the efficiency of photodissociation and is consistent with 




 Although the peptides investigated 
here incorporate aromatic residues, different peptide structures elicit only minor changes in 
the photodissociation profile. Based on the data in Figure 5, we speculate that an additional 
chromophore installed within the TEMPO-Bz derivative would increase the radical 
photoproduct yield when coupled to peptides, due to more efficient energy transfer into the 
NO-C bond. Extensive dissociation in such systems may even lead to secondary radical-
driven fragmentation of the peptide within a single activation step, providing sufficient 
diagnostic information for peptide sequencing. If realised this scenario could remove the need 
for subsequent collisional activation and thus avoid the low-mass cut-off inherent in the use 
of ion traps for CID. These insights will therefore inform future design of more photolabile 
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